Skip to content

comparative study of methyprednisolone and sphenopalatine block in spinal headache after obstretrics and gynecological surgery

A study to compare efficacy of oral methylprednisolone and sphenopalatine block in postdural puncture headache - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068282
Enrollment
30
Registered
2024-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O894- Spinal and epidural anesthesia-induced headache during the puerperium

Interventions

Intervention1: Methylprednisolone: Methylprednisolone 8 mg OD for 5 days Control Intervention1: Sphenopalatine block: Sphenopalatine block with Bupivacaine 2% intranasal route sos with maximum three t

Sponsors

Dr Mohd Rasheed
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who developed postdural puncture headache after spinal anesthesia in obstetrics and gynaecology surgical procedure

Exclusion criteria

Exclusion criteria: Patients with h/o migraine or other types of headache Neurological disorders Cerebrovascular accidents Cerebrovascular infection Conditions where methylprednisolone is contraindicated

Design outcomes

Primary

MeasureTime frame
Relief with symptoms by Visual Analogue scaleTimepoint: on day 0 followed by day 1, day 2, day 3,day 4 and day 5

Secondary

MeasureTime frame
1. Number of days with headache according to visual analogue scale 2. Toal Hospitalization days due to headacheTimepoint: 1. On day 0(on the day of presentation), day 1, day 2, day 3,day 4 & day 5 2. Total number of days patient required to stay in hospital due to headache

Countries

India

Contacts

Public ContactAnkushsinh Bhadoria

Command Hospital Air Force Bangalore

rashiddr81077@gmail.com9906904070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026